/ Print /

LATEST

Top 2018 challenges healthcare executives face
Top 2018 challenges healthcare executives faceExperts weigh in on the findings from Managed Healtcare Executive’s 2017 State of the Industry Survey.
New RA drugs and pipeline developments to watchTreating RA is a work in progress. Here’s what you need to know.
Kentucky opioid program drops dispensing by 50%Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.
Top ways to curtail gender bias in healthcareGender bias in patient care has damaging effects, especially for women.
Six healthcare marketing trends for 2018Here are six healthcare impact trends that will challenge marketers in the upcoming year.
Three things to know about Trump’s HHS lead pick AzarExperts share more about Alex Azar’s background and predict what his top agenda items are likely to be.
Stem cell therapy shows promise for COPD, but questions remainAutologous stem cell therapy may offer hope for patients with COPD. But some say caution is necessary.
Study defines ‘low-value care,’ evaluates toll on healthcare industryA new study led by UCLA researchers has eye-opening findings about low-cost, high-volume unnecessary healthcare. These low-value services may surprise you.
Federal program aimed at reducing readmissions raises concernsA new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.
How treating opioid use disorder is cost effectiveA commercial health plan analysis by axialHealthcare has interesting findings about funding opioid use disorder treatment plans.